Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Beata Maćkowiak-Matejczyk"'
Autor:
Brian Slomovitz, David Cibula, Murat Gultekin, Mansoor Mirza, Beata Maćkowiak-Matejczyk, Alexandra Taylor, Ignacio Romero, Nicoletta Colombo, Jacob Korach, Jianqing Zhu, Lucy Gilbert, Kosei Hasegawa, Jae-Weon Kim, Sally Baron-Hay, Vicky Makker, Robert L Coleman, Robert J Orlowski, Xuan Zhou, Vivek Khemka, Sandro Pignata
Publikováno v:
E-Posters (Trials In Progress).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b29036b0552c1d4c5ee0b960aebf9586
https://doi.org/10.1136/ijgc-2022-igcs.525
https://doi.org/10.1136/ijgc-2022-igcs.525
Autor:
Krishnansu S, Tewari, Bradley J, Monk, Ignace, Vergote, Austin, Miller, Andreia C, de Melo, Hee-Seung, Kim, Yong Man, Kim, Alla, Lisyanskaya, Vanessa, Samouëlian, Domenica, Lorusso, Fernanda, Damian, Chih-Long, Chang, Evgeniy A, Gotovkin, Shunji, Takahashi, Daniella, Ramone, Joanna, Pikiel, Beata, Maćkowiak-Matejczyk, Eva M, Guerra Alía, Nicoletta, Colombo, Yulia, Makarova, Danny, Rischin, Stephanie, Lheureux, Kosei, Hasegawa, Keiichi, Fujiwara, Jingjin, Li, Shaheda, Jamil, Vladimir, Jankovic, Chieh-I, Chen, Frank, Seebach, David M, Weinreich, George D, Yancopoulos, Israel, Lowy, Melissa, Mathias, Matthew G, Fury, Ana, Oaknin, Rachna T, Shroff
Publikováno v:
Obstetrical & Gynecological Survey. 77:348-350
Background: Patients with recurrent cervical cancer have a poor prognosis. Cemiplimab, the fully human programmed cell death 1 (PD-1)-blocking antibody approved to treat lung and skin cancers, has been shown to have preliminary clinical activity in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61b695632bb95081113f9be0c7c4b18
https://doi.org/10.1097/01.ogx.0000834600.51705.68
https://doi.org/10.1097/01.ogx.0000834600.51705.68